Takeda (NYSE:TAK) (4502.T) said on Monday that the European Commission approved Pfizer (NYSE:PFE) and the company's ...

TOKYO -- U.S. proxy advisory firm Institutional Shareholder Services (ISS) is recommending shareholders vote against the ...

The European Commission (EC) has granted approval for Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin).

"I am extremely proud that Takeda has been recognized as one of the top ten employers in the world for 2024. This confirms ...

Takeda Pharmaceutical Company Limited (NYSE: TAK )’s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized ...

Step into the world of high-end collectible figures with the MOSHOW TOYS Progenitor Effect Takeda Shingen METAL FRAME, a ...

Japanese rookie Rio Takeda finished tied for second at the U.S. Women's Open on Sunday as overnight leader Maja Stark of Sw ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

Takeda (NYSE:TAK) (4502.T) said on Monday that the European Commission approved Pfizer (NYSE:PFE) and the company's antibody-drug conjugate, Adcetrix, in combination with a chemotherapy regimen in ...

We are pleased to partner with Takeda as we continue to advance rusfertide to potentially transform the standard of care in PV patients around the world.” “These promising pivotal data ...

Japanese household spending unexpectedly fell in April, government data showed on Friday, as consumers tightened their purse ...

Takeda Pharmaceutical Company Limited (NYSE:TAK)’s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized by the European Commission on June 3, 2025, for newly diagnosed adult ...